Rosuvastatin cuts mortality in select patients with high CRP
by Marybeth Burke reporting on the presentation by Dr PM Ridker et al
“Compared
to those who received placebo, patients receiving the drug rosuvastatin also
had a 48% reduction in stroke, a 46% reduction in the need for interventions to
reopen blocked blood vessels and a 20% drop in all-cause mortality”
Read More »
|
Rosuvastatin - Anti-inflammatory effect benefits heart failure patients
by Marybeth Burke reporting on the presentation by Dr J McMurray
Rosuvastatin
showed an LDL independent reduction in cardiovascular morbidity and mortality
in heart failure patients with an elevated high sensitivity C-reactive protein
(hsCRP), according to a retrospective...
Read More »
|
DES in diabetic patients better than BMS
by Marybeth Burke reporting on the presentation by Dr L Mauri et al
“DES
were superior to BMS with regard to the need to repeat revascularisation. And not only was there no hazard with DES,
there was a statistical benefit with regard to death and MI with DES”
Read More »
|
Early Cath Lab critical for high risk patients
by Marybeth Burke reporting on the presentation by Dr SR Mehta et al
High risk acute coronary syndrome (ACS) patients benefit by getting to
the cath lab as early as possible, according to a study presented...
Read More »
|
Changes in the heart seen in obese children
by Marybeth Burke
“Among
children we do see higher blood pressure, changes in waist circumference and
changes in triglycerides which are all going in the wrong direction,
unfortunately. We need to focus on the
prevention of childhood obesity”
Read More »
|
Tailored clopidogrel cuts stent clotting
by Marybeth Burke reporting on the presentation by Dr E Antman et al
Tailored clopidogrel dosing significantly
cut the rate of adverse events after non-emergent percutaneous coronary
intervention (PCI) with stenting at thirty days, according...
Read More »
|
METEOR study aids trial design options
by Marybeth Burke reporting on the presentation by Dr GW Evans et al
Using information from the METEOR study, investigators asked the
question, what if you changed the pattern of scans in the study, what impact
would it have...
Read More »
|
Exercise safe for many heart failure patients
by Marybeth Burke reporting on the presentation by Dr CM O'Connor et al
Exercise training is safe in heart failure patients and is associated
with certain improved clinical outcomes, but does not significantly reduce
hospitalisation or death...
Read More »
|
Better ways to study diabetes drugs
by Marybeth Burke reporting on the presentation by Dr RM Califf
The
clinical trials system needs to be revamped and trials concerning diabetes
drugs can be done “quicker, better, and cheaper,” than they are currently being
done...
Read More »
|
Novel anti-clotting drug moves into phase III
by Marybeth Burke reporting on the presentation by Dr M Gibson et al
Rivaroxaban
exhibited a trend toward efficacy in reducing ischaemic events when combined
with antiplatelet therapy, according to data...
Read More »
|
LDL-P better predictor of CHD in some patients
by Marybeth Burke reporting on the presentation by Dr R Rosenson
“Patients with metabolic syndrome may have normal LDL-C, but not normal
LDL-P, which may underestimate the risk for coronary heart disease”
Read More »
|
Hibiscus tea lowers blood pressure
by Marybeth Burke
Drinking three cups of hibiscus tea daily appears to lower blood
pressure in pre - and mildly hypertensive adults and could be important for
people at risk of developing high blood pressure, according...
Read More »
|
Treatment guidelines may leave some patients at risk
by Marybeth Burke reporting on the presentation by Dr CM Ballantyne
Physicians
may have to reduce non-high density lipoprotein cholesterol (non-HDL) and LDL
cholesterol beyond current guidelines in order to achieve apolipoprotein (Apo)
B goals in diabetic and...
Read More »
|
